Burning Rock Biotech Limited
BNR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $66,306 | $24,374 | $35,141 | $50,942 |
| - Cash | $463,994 | $452,721 | $495,145 | $519,849 |
| + Debt | $33,180 | $39,126 | $42,338 | $52,321 |
| Enterprise Value | -$364,508 | -$389,221 | -$417,666 | -$416,586 |
| Revenue | $131,617 | $148,554 | $133,082 | $126,022 |
| % Growth | -11.4% | 11.6% | 5.6% | – |
| Gross Profit | $98,844 | $108,103 | $97,401 | $89,422 |
| % Margin | 75.1% | 72.8% | 73.2% | 71% |
| EBITDA | -$3,284 | $1,350 | -$15,179 | -$46,800 |
| % Margin | -2.5% | 0.9% | -11.4% | -37.1% |
| Net Income | -$16,758 | -$9,702 | -$13,500 | -$81,294 |
| % Margin | -12.7% | -6.5% | -10.1% | -64.5% |
| EPS Diluted | -15.6 | -9 | -12.5 | -78.7 |
| % Growth | -73.3% | 28% | 84.1% | – |
| Operating Cash Flow | $16,394 | -$44,349 | -$23,527 | $19,062 |
| Capital Expenditures | $0 | $0 | $0 | -$5,419 |
| Free Cash Flow | $16,394 | -$44,349 | -$23,527 | $13,643 |